LIVN Q3 2017 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$310M+4.9% YoY

Gross Profit

$200M64.5% margin

Operating Income

$32M10.4% margin

Net Income

$28M9.0% margin

EPS (Diluted)

$0.57

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

$33M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$689M

Stockholders' Equity

$1.9B

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$310M	$295M	+4.9%
Gross Profit	$200M	$189M	+5.8%
Operating Income	$32M	$23M	+39.5%
Net Income	$28M	-$2M	+1873.7%

Revenue Segments

Cardiac Surgery

$160M52%

Neuromodulation

$91M29%

Cardiac Rhythm Management

$58M19%

Geographic Segments

UNITED STATES

$122M36%

Non-U.S. and Europe

$95M28%

Europe

$93M27%

FRANCE

$30M9%